REFRACTORY HEPATOBLASTOMA
Clinical trials for REFRACTORY HEPATOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY HEPATOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY HEPATOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough cancers: two drug combos enter trial
Disease control Recruiting nowThis study is for children and young adults (ages 1 to 30) whose solid tumors have come back or never fully went away. It tests two different drug combinations that damage cancer cell DNA to kill the tumor. The goal is to find the safest dose and see if the tumors shrink or disap…
Matched conditions: REFRACTORY HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 11:50 UTC
-
New hope for young cancer patients: experimental drug targets tough tumors
Disease control Recruiting nowThis study tests a drug called tegavivint in children, teens, and young adults (ages 1 to 30) whose solid tumors have returned or not responded to standard therapy. The drug works by blocking a key signal that tells cancer cells to grow. The trial aims to find the safest dose, un…
Matched conditions: REFRACTORY HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 11:45 UTC
-
New registry aims to crack the code on childhood liver cancer that won't go away
Knowledge-focused Recruiting nowThis study is creating a registry of up to 500 children and adults whose liver cancer (hepatoblastoma) has come back or not responded to treatment. Researchers will collect medical information, tumor samples, and scans to better understand the disease. The goal is to improve futu…
Matched conditions: REFRACTORY HEPATOBLASTOMA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 26, 2026 11:55 UTC